{
"@context": "https://schema.org",
"@graph": [
{
"@type": "WebPage",
"@id": "https://www.fortrea.com/insights/exceeding-challenging-milestones-through-teamwork-and-innovation#webpage",
"url": "https://www.fortrea.com/insights/exceeding-challenging-milestones-through-teamwork-and-innovation",
"name": "Exceeding challenging milestones through teamwork and innovation",
"description": "This Fortrea case study highlights how a small biopharmaceutical sponsor conducting a global Phase III pivotal trial for a rare genetic cardiovascular disease achieved ambitious study start-up milestones despite significant operational challenges. With a requirement to enroll the first patient within six months of award and competition from a rival study already engaging many leading sites, the program required an innovative and highly proactive approach to site identification, patient finding, and trial infrastructure development. Working from a protocol synopsis, Fortrea leveraged cardiovascular expertise, academic relationships, and rapid start-up capabilities to identify suitable investigative sites, educate teams on the disease’s unique manifestations, support multispecialty collaboration, and prepare both cardiology and noncardiology sites for study-specific assessments. The team initiated site outreach and infrastructure planning before protocol finalization, while also addressing the challenge of identifying eligible patients within a rare population that required extensive genotype and phenotype screening. Through teamwork, flexibility, scientific expertise, and innovative problem-solving, Fortrea helped the sponsor navigate a competitive landscape and progress toward critical Phase III development milestones."
},
{
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "Home",
"item": "https://www.fortrea.com"
},
{
"@type": "ListItem",
"position": 2,
"name": "Insights",
"item": "https://www.fortrea.com/insights/"
},
{
"@type": "ListItem",
"position": 3,
"name": "Exceeding challenging milestones through teamwork and innovation",
"item": "https://www.fortrea.com/insights/exceeding-challenging-milestones-through-teamwork-and-innovation"
}
]
},
{
"@type": "Organization",
"@id": "https://www.fortrea.com/#organization",
"name": "Fortrea",
"url": "https://www.fortrea.com",
"description": "Fortrea is a global contract research organization built on more than 30 years of experience and one of the earliest CRO legacies in the industry—as Covance, evolving within Labcorp, and now operating as Fortrea. With deep expertise across Phase I–IV clinical trials, Fortrea advances clinical research through a patient-centric approach that prioritizes meaningful outcomes, stronger site–CRO relationships, and operational excellence. Fortrea partners with biopharmaceutical, biotech, and medical device companies to advance therapies through every stage of clinical development. This commitment is further reinforced by the launch of Fortrea Intelligent Technology, enabling smarter, more connected, and data-driven clinical development. Through Fortrea Intelligent Technology, the organization is advancing data-driven, technology-enabled clinical development to improve speed, quality, and patient outcomes. It is shaped by experience, innovation, and a commitment to raising standards in clinical research—focused on accelerating development and helping bring life-changing treatments to patients around the world.",
"logo": "https://www.fortrea.com/sites/default/files/2025-05/fortrea-logo-without-background.png",
"sameAs": [
"https://www.linkedin.com/company/fortrea",
"https://www.threads.net/@fortreacro",
"https://twitter.com/fortrea",
"https://www.youtube.com/@Fortrea/",
"https://www.facebook.com/Fortrea-104143099267108",
"https://www.instagram.com/fortreacro"
]
},
{
"@type": "Article",
"@id": "https://www.fortrea.com/insights/exceeding-challenging-milestones-through-teamwork-and-innovation#casestudy",
"mainEntityOfPage": {
"@id": "https://www.fortrea.com/insights/exceeding-challenging-milestones-through-teamwork-and-innovation#webpage"
},
"headline": "Rare Disease Clinical Trial Start-Up: Achieving Aggressive Phase III Milestones in a Global Cardiovascular Study | Fortrea Case Study",
"description": "This Fortrea case study highlights how a small biopharmaceutical sponsor conducting a global Phase III pivotal trial for a rare genetic cardiovascular disease achieved ambitious study start-up milestones despite significant operational challenges. With a requirement to enroll the first patient within six months of award and competition from a rival study already engaging many leading sites, the program required an innovative and highly proactive approach to site identification, patient finding, and trial infrastructure development. Working from a protocol synopsis, Fortrea leveraged cardiovascular expertise, academic relationships, and rapid start-up capabilities to identify suitable investigative sites, educate teams on the disease’s unique manifestations, support multispecialty collaboration, and prepare both cardiology and noncardiology sites for study-specific assessments. The team initiated site outreach and infrastructure planning before protocol finalization, while also addressing the challenge of identifying eligible patients within a rare population that required extensive genotype and phenotype screening. Through teamwork, flexibility, scientific expertise, and innovative problem-solving, Fortrea helped the sponsor navigate a competitive landscape and progress toward critical Phase III development milestones.",
"genre": "Case Study",
"image": {
"@type": "ImageObject",
"url": "https://www.fortrea.com/sites/default/files/2024-11/GettyImages-1191676451.webp"
},
"author": {
"@type": "Organization",
"name": "Fortrea",
"url": "https://www.fortrea.com/"
},
"publisher": {
"@id": "https://www.fortrea.com/#organization"
},
"datePublished": "2024-11-14",
"dateModified": "2024-11-14",
"encoding": {
"@type": "MediaObject",
"contentUrl": "https://www.fortrea.com/sites/default/files/2024-11/CS%200036%20Exceeding%20Challenging%20Milestones%200723%20HiRes%20%281%29.pdf",
"encodingFormat": "application/pdf"
}
}
]
}